Celltrion, Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

Explore the PTAB proceeding IPR2023-00532 filed by Celltrion, Inc. et al. on 2023-02-10. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2023-00532

Filing Date

2023-02-10

Accorded Filing Date

2023-02-10

Institution Decision Date

2023-03-22

Last Modified Date

2024-08-23

Proceeding Type

IPR

Termination Date

2024-01-09

Trial Status

Final Written Decision

Parties & Counsel

Petitioner

Celltrion, Inc. et al.

Represented By

Green, Loraet al

Patent Owner / Respondent

Regeneron Pharmaceuticals, Inc.

Represented By

Fishman, Deborahet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 15471506

Respondent Patent Number 10130681

External Links

Espacenet

Google Patents

Respondent Inventor George D. YANCOPOULOS

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

23 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name A&P - Regeneron (Prosecution)

Customer Number 191459

Address 601 Massachusetts Ave., NW, Washington, DC, 20001-3743, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
41408	David Marsh	202-942-5068
48001	Thomas Triolo	914-847-1612
48921	Stephen Gaudet	914-847-7376
50370	Neil Miyamoto	914-847-7175
50437	Frank Cottingham	914-593-1116
58583	Brian Cocca	914-847-1421
58714	Ilona Gont	914-847-1304
59668	Brandon Schurter	914-847-7000
60281	Aparna Patankar	914-847-5571
61391	Yonghao Hou	914-839-2555
61915	Yongjin Choi	914-847-5384
65789	Margarita Zippin	914-847-5589
65957	Lisa Flanagan	914-847-8175
67881	Eileen Woo	914-847-1246
68046	Elysa Goldberg	914-847-1280
68059	David Mellman	720-391-8767
68136	Christopher Westberg	914-847-7912
71406	Gabriele Amodeo	914-847-3578
73212	Trisha Agrawal	914-313-7694
74751	Casey Donahoe	814-931-8622
76829	Michael Lewis	202-942-6728
77536	Alyson Nickols	640-448-3073
81783	Alice Ho	202-942-6753

Proceeding Documents

112

Other: Fed Circuit mandate OTHER

2024-08-23 FILING PARTY: BOARD

Download

JUDGMENT Final Written Decision Denying in Part, Granting in Part, and Dismissing in Part Petitioner’s Motion to Exclude Evidence, Denying in Part and Dismissing in Part Patent Owner’s Motion to Exclude Evidence, Determining Challenged Claims 1, 3–11, 13, 14, 16–24, and 26 Unpatentable 35 U.S.C. § 318(a) FINAL

2024-01-09 FILING PARTY: BOARD

Download

Petitioner's Updated Power of Attorney NOTICE

2023-04-28 FILING PARTY: PETITIONER

Download

Petitioner's Updated Mandatory Notice NOTICE

2023-04-28 FILING PARTY: PETITIONER

Download

Institution Decision: Joined OTHER

2023-03-22 FILING PARTY: BOARD

Download

Celltrion, Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

Proceeding Overview

Parties & Counsel

Petitioner

Celltrion, Inc. et al.

Represented By

Patent Owner / Respondent

Regeneron Pharmaceuticals, Inc.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Other: Fed Circuit mandate OTHER

Petitioner's Updated Power of Attorney NOTICE

Petitioner's Updated Mandatory Notice NOTICE

Institution Decision: Joined OTHER

Ex. 3001 Exhibit

Notice : Power of Attorney NOTICE

Notice : Mandatory Notice NOTICE

Notice : Mandatory Notice NOTICE

Notice : Power of Attorney NOTICE

Notice: NOTICE OF FILING DATE ACCORDED TO PETITION AND TIME FOR FILING PATENT OWNER PRELIMINARY RESPONSE NOTICE

IPR2021-00881 Ex.1110, David M. Brown Deposition Transcript (Apr. 26, 2022) Exhibit

Kristina Zucchi, EDGAR (Jan. 31. 2014) Exhibit

Geeta A. Lalwani et al. (2009) Exhibit

CENTER FOR DRUG EVAL. & RESEARCH, BLA No. 125-387, Eylea Medical Review Exhibit

Candelaria Gomez-Manzano et al. (2008) Exhibit

J.S. Rudge et al., (2005) Exhibit

Press Release, Regeneron (Aug. 19, 2008) Exhibit

Monthly Dosing Patents: 7,303,746 ; 7,303,747 ; 7,306,799 & 7,521,049 Exhibit

Polly A. Quiram & Yahui Song (2009) Exhibit

Adis R&D Profile, Aflibercept: AVE 0005 Exhibit

Press Release, Regeneron (March 27, 2007) Exhibit

Retina Society, VEGF Trap-Eye in Wet AMD CLEAR-IT 2 (Sep. 8, 2008) Exhibit

Jeffrey S. Heier et al. Exhibit

Press Release, Regeneron (Feb. 26, 2009) Exhibit

CENTER FOR DRUG EVALUATION & RESEARCH, BLA No. 125156, Lucentis Med. Review Exhibit

Expert Declaration of Mary Gerritsen, Ph.D. Exhibit

John S. Rudge et al. (2008) Exhibit

Napoleone Ferrara & Robert S. Kerbel (2005) Exhibit

Press Release, Bayer AG (May 8, 2008) Exhibit

U.S. Patent No. 7,374,758 B2 (“‘758 patent”) Exhibit

U.S. Patent No. 7,378,095 B2 Exhibit

Eugene S. Kim et al. (2002) Exhibit

European Patent No. 3 222 285 Exhibit

Quan Dong Nguyen et al. (2006) Exhibit

File History of European Patent No. 3 222 285 Exhibit

Quan Dong Nguyen et al., Exhibit

Philip J. Rosenfeld et al. (2006) Exhibit

BMJ Publishing Group Ltd., Review: Ranibizumab (Lucentis) (Dec. 2020) Exhibit

BMJ Publishing Group Ltd., Online First, BJO ONLINE, (Feb. 11, 2009) Exhibit

James A Dixon et al. Exhibit

Expert Declaration of Dr. Thomas A. Albini Exhibit

Corporate Finance Institute, SEC Filings (May 5, 2021) Exhibit

Ziad F. Bashshur et al. (2006) Exhibit

IPR2021-00881, Ex.2003, Lucentis (ranibizumab injection) Label, revised Exhibit

Curriculum Vitae of Dr. Mary Gerritsen Exhibit

Christopher Wirbelauer (2006) Exhibit

LUCENTIS® Prescribing Information (2006) Exhibit

U.S. Patent App., Publication No. 2006/0217311 A1 (“Dix”) Exhibit

Thomas A. Ciulla & Philip J. Rosenfeld (2009) Exhibit

Jorma B. Mueller & Christopher M. McStay (2008) Exhibit

U.S. DEP’T HEALTH & HUMAN SERVS., NIH, NAT’L EYE INST., Sep. 2015 Exhibit

L. Spielberg & A. Leys (2009) Exhibit

Press Release, Regeneron (May 8, 2008) Exhibit

Notice : Power of Attorney NOTICE

Jocelyn Holash et al., VEGF-Trap Exhibit

Amino acid sequence alignment of SEQ ID NO:2 of the ’681 and ’601 patents Exhibit

Pearse A. Keane et al. (2009) Exhibit

IPR2021-00881 Ex.1109, Diana V. Do Deposition Transcript (April 21, 2022) Exhibit

European Patent No. 2 663 325 (published as WO 2012/097019 A1) Exhibit

Motion : Joinder MOTION

Erik Christensen (2007) Exhibit

ClinicalTrials.gov, What Is ClinicalTrials.gov?, U.S. NAT’L LIBRARY MED. Exhibit

Hamish M. Fraser et al. (2008) Exhibit

P Mitchell et al., (2009) Exhibit

U.S. DEP’T HEALTH & HUMAN SERVS., NIH, NAT’L EYE INST., (Sep. 2015) Exhibit